Patents by Inventor Stéphane Rioux

Stéphane Rioux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20160326221
    Abstract: The present invention relates to antigens more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: April 14, 2016
    Publication date: November 10, 2016
    Inventors: Denis Martin, Bernard R. Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • Streptococcus pyogenes antigens and corresponding DNA fragments
    Patent number: 9340586
    Abstract: The present invention relates to antigens more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: May 17, 2016
    Assignee: ID BIOMEDICAL CORPORATION OF QUEBEC
    Inventors: Denis Martin, Bernard R. Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • Treatment of streptococcal infections
    Patent number: 9314518
    Abstract: Methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: April 19, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Denoel, Philippe Vincent Hermand, Steve Labbe, Jan Poolman, Stephane Rioux
  • STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20150017684
    Abstract: The present invention relates to antigens more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: July 31, 2014
    Publication date: January 15, 2015
    Inventors: Denis Martin, Bernard R. Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • antigens and corresponding DNA fragments
    Patent number: 8821895
    Abstract: The present invention relates to antigens, more particularly antigenS of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: September 2, 2014
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Denis Martin, Bernard R. Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • TREATMENT OF STREPTOCOCCAL INFECTIONS
    Publication number: 20140205634
    Abstract: Methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Application
    Filed: February 10, 2014
    Publication date: July 24, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe DENOEL, Philippe Vincent HERMAND, Steve LABBE, Jan POOLMAN, Stephane RIOUX
  • TREATMENT OF STREPTOCOCCAL INFECTIONS
    Publication number: 20120328659
    Abstract: Immunogenic compositions and methods of treating a Streptococcus pneumoniae infection are described herein.
    Type: Application
    Filed: March 8, 2011
    Publication date: December 27, 2012
    Inventors: Philippe Denoel, Philippe Vincent Hermand, Steve Labbe, Jan Poolman, Stephane Rioux
  • antigens and corresponding DNA fragments
    Patent number: 8298551
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: October 30, 2012
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Denis Martin, Bernard R. Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • Methods for using polypeptides
    Patent number: 7883706
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 8, 2011
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • antigens
    Patent number: 7811585
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: July 9, 2007
    Date of Patent: October 12, 2010
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Group B antigens and corresponding DNA fragments
    Patent number: 7740870
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: June 22, 2010
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
  • STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20100119507
    Abstract: The present invention relates to antigens, more particularly antigenS of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: September 28, 2009
    Publication date: May 13, 2010
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • antigens and corresponding DNA fragments
    Patent number: 7595057
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: September 29, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090186820
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Application
    Filed: January 12, 2009
    Publication date: July 23, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • MORAXELLA (BRANHAMELLA) CATARRHALIS ANTIGENS
    Publication number: 20090074807
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: July 15, 2008
    Publication date: March 19, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • GROUP B STREPTOCOCCUS ANTIGENS AND CORRESPONDING DNA FRAGMENTS
    Publication number: 20090042794
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: June 9, 2008
    Publication date: February 12, 2009
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Martine Boyer
  • polypeptides and corresponding DNA fragments
    Patent number: 7482012
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for prophylaxis, therapy and/or diagnostic.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: January 27, 2009
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Patrick Rheault
  • BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS
    Publication number: 20080227706
    Abstract: Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: January 22, 2008
    Publication date: September 18, 2008
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee Hamel, Bernard R. Brodeur
  • () antigens
    Patent number: 7410645
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) catarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture
  • Polypeptides of ()
    Patent number: 7410648
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 12, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Denis Martin, Josée Hamel, Bernard R. Brodeur, Stéphane Rioux, Julie Couture